Creative Biolabs has expanded its complement testing capabilities to help researchers overcome challenges in complement drug development through comprehensive complement activity assays, CH50 ...
Drug-resistant epilepsy (DRE) presents significant challenges in treatment and management. While seizure-related alterations in peripheral immune players are increasingly recognized, the involvement ...
Autoimmune related kidney diseases (ARKDs), including minimal change nephropathy (MCN), membranous nephropathy (MN), IgA nephropathy (IgAN), and lupus nephritis (LN), significantly affect renal ...
While agents like AbbVie's Humira have transformed the treatment landscape, not all patients benefit equally from the drug.
Please provide your email address to receive an email when new articles are posted on . A protein known as granzyme K was recently shown to be a driver of inflammation by activating the complement ...
The promise of precision medicine in immunology is both daunting and profound: tailoring treatment to each person’s unique biology to achieve better outcomes. This approach has revolutionized oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results